{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:16:22Z","timestamp":1759058182386},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.jviromet.2004.01.009","type":"journal-article","created":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T05:07:13Z","timestamp":1077167233000},"page":"179-187","source":"Crossref","is-referenced-by-count":25,"title":["Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR"],"prefix":"10.1016","volume":"117","author":[{"given":"Johanna A.C.","family":"Schalk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"van den Elzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Ovelg\u00f6nne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Baas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.J.M.","family":"Jongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2004.01.009_BIB1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/377103","article-title":"Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands","volume":"188","author":"Van Binnendijk","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2004.01.009_BIB2","unstructured":"Davis, B.D., Dulbecco, R., Eisen, H.N., Ginsberg, H.S., 1990. Microbiology, fourth ed. J.B. Lippincott Company, Philadelphia, pp. 787\u2013794."},{"key":"10.1016\/j.jviromet.2004.01.009_BIB3","unstructured":"European Pharmacopoeia, 2002. Fourth ed. Directorate for the Quality of Medicines of the Council of Europe (EDQM), Strasbourg, France."},{"key":"10.1016\/j.jviromet.2004.01.009_BIB4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1045-1056(05)80042-9","article-title":"A collaborative study to assess the proficiency of laboratory estimates of potency of live measles vaccines","volume":"20","author":"Forsey","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2004.01.009_BIB5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/biol.1993.1081","article-title":"A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines","volume":"21","author":"Forsey","year":"1993","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2004.01.009_BIB6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0166-0934(87)90150-9","article-title":"Immunocytochemical focus assay for potency determination of measles-mumps-rubella-trivalent vaccine","volume":"15","author":"Fukuda","year":"1987","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2004.01.009_BIB7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-0934(96)02064-2","article-title":"Parameters for plaque formation in potency assay of Japanese measles vaccines","volume":"61","author":"Fukuda","year":"1996","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2004.01.009_BIB8","unstructured":"Lewis, J.A., Ranheim, T.S., Wang, F., Moyer, P., Smith, M.E., Benz, R., Mathis, W.C., Schofield, T.L., Hager, A., 2001. Novel use of Q-PCR technology to assay the potency of live virus vaccines. Symposium Abstract. Well Characterized Biological Products, 5th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products."},{"key":"10.1016\/j.jviromet.2004.01.009_BIB9","unstructured":"Olsewski, L., 2001. Infectivity PCR: an alternative for viral clearance and inactivation studies. http:\/\/www.pda.org\/public%20presentations\/2001PDA-FDA-viralagenda.html."},{"key":"10.1016\/j.jviromet.2004.01.009_BIB10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3301731","article-title":"Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods","volume":"9","author":"Sastry","year":"2002","journal-title":"Gene Ther."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093404000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093404000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T21:27:46Z","timestamp":1550179666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093404000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0166093404000114"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2004.01.009","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}